Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mills

Showing results (971-980 of 1,016) with videos related to

Pageof 102
Sort By:
Gynecologic Oncology|March 30, 2024
The association of histopathologic features after neoadjuvant chemo-immunotherapy with clinical outcome: Sub-analyses from the randomized double-blinded, placebo-controlled, Phase III IMagyn050/GOG3015/ENGOT-ov39 studyPaulette Mhawech-Fauceglia, Denis McCarthy, Akiko Tonooka, et al.
Nature Communications|December 8, 2020
Synergistic interactions among growing stressors increase risk to an Arctic ecosystemK R Arrigo, Gert L van Dijken, M A Cameron, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 3, 2021
Advanced practice providers in academic emergency medicine: A national survey of chairs and program directorsChristopher R Carpenter, Stacy Abrams, D Mark Courtney, et al.
Journal of the American Society of Cytopathology|May 5, 2019
From slide sets to sound bites: teaching and learning pathology in the digital ageAnne M Mills, Marisa Meyers-Needham, Robin D LeGallo, et al.
American Heart Journal|October 11, 2011
Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AFJonathan P Piccini, Elizabeth S Fraulo, Jack E Ansell, et al.
The Lancet. HIV|May 11, 2024
Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trialAnthony M Mills, Giuliano Rizzardini, Moti N Ramgopal, et al.
Journal of Virology|November 8, 2013
New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusionArnab Basu, Aleksandar Antanasijevic, Minxiu Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2015
Clinically Relevant Molecular Subtypes in LeiomyosarcomaXiangqian Guo, Vickie Y Jo, Anne M Mills, et al.
Oncogene|January 24, 2012
Mitochondrial respiratory uncoupling promotes keratinocyte differentiation and blocks skin carcinogenesisC U Lago, S M Nowinski, J E Rundhaug, et al.
Journal of Clinical Medicine|May 11, 2024
Shorter Door-to-ECG Time Is Associated with Improved Mortality in STEMI PatientsMaame Yaa A B Yiadom, Wu Gong, Sean M Bloos, et al.
Pageof 102

Showing results (971-980 of 1,016) with videos related to

Sort By:
Pageof 102
Gynecologic Oncology|March 30, 2024
The association of histopathologic features after neoadjuvant chemo-immunotherapy with clinical outcome: Sub-analyses from the randomized double-blinded, placebo-controlled, Phase III IMagyn050/GOG3015/ENGOT-ov39 studyPaulette Mhawech-Fauceglia, Denis McCarthy, Akiko Tonooka, et al.
Nature Communications|December 8, 2020
Synergistic interactions among growing stressors increase risk to an Arctic ecosystemK R Arrigo, Gert L van Dijken, M A Cameron, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 3, 2021
Advanced practice providers in academic emergency medicine: A national survey of chairs and program directorsChristopher R Carpenter, Stacy Abrams, D Mark Courtney, et al.
Journal of the American Society of Cytopathology|May 5, 2019
From slide sets to sound bites: teaching and learning pathology in the digital ageAnne M Mills, Marisa Meyers-Needham, Robin D LeGallo, et al.
American Heart Journal|October 11, 2011
Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AFJonathan P Piccini, Elizabeth S Fraulo, Jack E Ansell, et al.
The Lancet. HIV|May 11, 2024
Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trialAnthony M Mills, Giuliano Rizzardini, Moti N Ramgopal, et al.
Journal of Virology|November 8, 2013
New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusionArnab Basu, Aleksandar Antanasijevic, Minxiu Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2015
Clinically Relevant Molecular Subtypes in LeiomyosarcomaXiangqian Guo, Vickie Y Jo, Anne M Mills, et al.
Oncogene|January 24, 2012
Mitochondrial respiratory uncoupling promotes keratinocyte differentiation and blocks skin carcinogenesisC U Lago, S M Nowinski, J E Rundhaug, et al.
Journal of Clinical Medicine|May 11, 2024
Shorter Door-to-ECG Time Is Associated with Improved Mortality in STEMI PatientsMaame Yaa A B Yiadom, Wu Gong, Sean M Bloos, et al.
Pageof 102